Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Jul;22(1):43–48. doi: 10.1111/j.1365-2125.1986.tb02878.x

Enhancement by sodium salicylate of the blood glucose lowering effect of chlorpropamide-drug interaction or summation of similar effects?

T Richardson, J Foster, G E Mawer
PMCID: PMC1401084  PMID: 3527244

Abstract

The ability of sodium salicylate (3 g) to enhance the blood glucose lowering action of chlorpropamide (200 mg) has been confirmed in healthy male volunteers who received an oral test dose of 50 g glucose. Salicylate raised the plasma concentration of insulin and lowered that of cortisol but did not alter the concentration of chlorpropamide. The area under the blood glucose concentration-time curve was used as the measure of drug response and the significance of drug effects was assessed by analysis of variance. In one study on five volunteers the effect of combining salicylate and chlorpropamide was additive. In a second study on six volunteers 200 mg chlorpropamide, 3 g sodium salicylate and 100 mg chlorpropamide + 1.5 g salicylate were equi-effective. The enhancement of chlorpropamide action by salicylate in this single dose study is consistent with the summation of similar effects. It is not necessary to postulate an interaction.

Full text

PDF
43

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CHERNER R., GROPPE C. W., Jr, RUPP J. J. PROLONGED TOLBUTAMIDE-INDUCED HYPOGLYCEMIA. JAMA. 1963 Sep 14;185:883–884. doi: 10.1001/jama.1963.03060110087026. [DOI] [PubMed] [Google Scholar]
  2. Chen M., Robertson R. P. Effects of prostaglandin synthesis inhibitors on human insulin secretion and carbohydrates tolerance. Prostaglandins. 1979 Oct;18(4):557–567. doi: 10.1016/0090-6980(79)90023-6. [DOI] [PubMed] [Google Scholar]
  3. Fang V., Foye W. O., Robinson S. M., Jenkins H. J. Hypoglycemic activity and chemical structure of the salicylates. J Pharm Sci. 1968 Dec;57(12):2111–2116. doi: 10.1002/jps.2600571218. [DOI] [PubMed] [Google Scholar]
  4. Field J. B., Boyle C., Remer A. Effect of salicylate infusion on plasma-insulin and glucose tolerance in healthy persons and mild diabetics. Lancet. 1967 Jun 3;1(7501):1191–1194. doi: 10.1016/s0140-6736(67)92842-5. [DOI] [PubMed] [Google Scholar]
  5. Giugliano D., Torella R., Siniscalchi N., Improta L., D'Onofrio F. The effect of acetylsalicylic acid on insulin response to glucose and arginine in normal man. Diabetologia. 1978 Jun;14(6):359–362. doi: 10.1007/BF01228129. [DOI] [PubMed] [Google Scholar]
  6. Hansen J. M., Christensen L. K. Drug interactions with oral sulphonylurea hypoglycaemic drugs. Drugs. 1977 Jan;13(1):24–34. doi: 10.2165/00003495-197713010-00003. [DOI] [PubMed] [Google Scholar]
  7. INGLE D. J. Effect of aspirin upon glycosuria of the partially depancreatized rat. Proc Soc Exp Biol Med. 1950 Dec;75(3):673–674. doi: 10.3181/00379727-75-18301. [DOI] [PubMed] [Google Scholar]
  8. Kane J. W. Use of sodium salicylate as a blocking agent for cortisol-binding-globulin in a radioimmunoassay for cortisol on unextracted plasma. Ann Clin Biochem. 1979 Jul;16(4):209–212. doi: 10.1177/000456327901600149. [DOI] [PubMed] [Google Scholar]
  9. RANDLE P. J., SMITH G. H. Regulation of glucose uptake by muscle. 1. The effects of insulin, anaerobiosis and cell poisons on the uptake of glucose and release of potassium by isolated rat diaphragm. Biochem J. 1958 Nov;70(3):490–500. doi: 10.1042/bj0700490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Richardson T. A modification of the Trinder AutoAnalyzer method for glucose. Ann Clin Biochem. 1977 Jul;14(4):223–226. doi: 10.1177/000456327701400160. [DOI] [PubMed] [Google Scholar]
  11. SMITH M. J. H. The effect of salicylate on the glycosuria and hyperglycaemia induced by cortisone in the normal rat. Biochem J. 1952 Dec;52(4):649–652. doi: 10.1042/bj0520649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. STOWERS J. M., CONSTABLE L. W., HUNTER R. B. A clinical and pharmacological comparison of chlorpropamide and other sulfonylureas. Ann N Y Acad Sci. 1959 Mar 30;74(3):689–695. doi: 10.1111/j.1749-6632.1959.tb39597.x. [DOI] [PubMed] [Google Scholar]
  13. TRINDER P. Rapid determination of salicylate in biological fluids. Biochem J. 1954 Jun;57(2):301–303. doi: 10.1042/bj0570301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. WISHINSKY H., GLASSER E. J., PERKAL S. Protein interactions of sulfonylurea compounds. Diabetes. 1962;11(Suppl):18–25. [PubMed] [Google Scholar]
  15. Woods H. F., Stubbs W. A., Johnson G., Alberti K. G. Inhibition by salicylate of gluconeogenesis in the isolated perfused rat liver. Clin Exp Pharmacol Physiol. 1974 Nov-Dec;1(6):535–540. doi: 10.1111/j.1440-1681.1974.tb00574.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES